JB/CALL/POLE GROU/27.5/0.1/20.12.24 | Market Closed - Swiss Exchange 16:20:00 28/06/2024 BST | ||
| 0.57 CHF | -8.06% |
|
| 1 month | -35.23% | ||
| 3 months | -24.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 0.57 | -8.06% |
| 27/06/24 | 0.62 | +1.64% |
| 26/06/24 | 0.61 | -8.96% |
| 25/06/24 | 0.67 | -9.46% |
| 24/06/24 | 0.74 | -2.63% |
Delayed Quote Swiss Exchange
Last update June 28, 2024 at 04:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPYEJB | |
| ISIN | CH1284780884 |
| Date issued | 23/08/2023 |
| Strike | 27.5 CHF |
| Maturity | 20/12/2024 (172 Days) |
| Parity | 10 : 1 |
| Emission price | 0.61 CHF |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.96 CHF |
|---|---|
| Lowest since issue | 0.07 CHF |
| Spread | 0.01 CHF |
| Spread % | 1.72% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
29.51
EUR
Average target price
26.74
EUR
Spread / Average Target
-9.39%
- Stock Market
- Warrants
- PPYEJB Warrant
